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Abstract
Background: Fibrin pupillary-block glaucoma is a rare complication after cataract surgery. The treatment for this
condition is still controversial, since Nd:YAG laser fibrin membranotomy tends to reocclude and laser peripheral
iridotomy entails the risk of damaging the corneal endothelium in the presence of corneal edema associated with
elevated intraocular pressure.
Case presentation: A 62-year-old man with diabetes mellitus developed acute elevation of intraocular pressure
with a shallow anterior chamber five days after uneventful cataract surgery. Initially, slit lamp examination provided
only limited information due to severe corneal edema. After resolution of corneal edema with systemic glaucoma
therapy, a complete fibrin membrane was observed across the pupil by slit lamp examination. Anterior segment
optic coherence tomography clearly revealed a thin fibrin membrane covering the entire pupillary space, a shallow
anterior chamber, and a deep posterior chamber. The intraocular lens was not observed by anterior segment optic
coherence tomography. In contrast, ultrasound biomicroscopy, which has superior penetration depth, was able to
visualize the intraocular lens deep in the posterior chamber. Injection of tissue plasminogen activator into the
anterior chamber resulted in complete fibrinolysis and released the pupillary block.
Conclusion: This case suggests that ocular anterior segment imaging modalities, especially ultrasound
biomicroscopy, serve as powerful diagnostic tools to identify mechanisms of acute angle closure glaucoma, which
is often accompanied by poor intraocular visibility. This is the first reported case of fibrin pupillary-block glaucoma
after cataract surgery successfully treated with intracameral tissue plasminogen activator.
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Background
Fibrin membrane pupillary-block glaucoma is an
uncommon complication after phacoemulsification cat-
aract surgery [1]. Severe corneal edema due to elevated
intraocular pressure often prevents a thorough slit lamp
examination, making early diagnosis difficult. Corneal
edema similarly interferes with laser iridotomy. We pre-
sent here a case of fibrin membrane pupillary-block
glaucoma that was diagnosed with help of ocular ante-
rior segment imaging devices and successfully treated
with tissue plasminogen activator.
Case presentation
The patient was a 62-year-old Japanese man with dia-
betes mellitus on insulin therapy for 20 years. He visited
an ophthalmology unit in a general hospital to check for
diabetic retinopathy. His visual acuity was 0.5 in the right
eye and 0.3 in the left eye. Intraocular pressure (IOP) was
13 mmHg and 14 mmHg in the right and left eyes,
respectively. The anterior chambers were deep and clear
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any medium, provided the original work is properly cited.in both eyes. Examination revealed cortical cataract and
pre-proliferative diabetic retinopathy in the both eyes.
Uneventful phacoemulsification cataract surgery with in-
the-bag intraocular lens (IOL) implantation was per-
formed in the left eye on March 10, 2011, when his blood
glucose level was 98 mg/dl, and his HbA1c was 7.4%. On
the next day, the visual acuity was 0.8, and IOP was 15
mmHg. The anterior chamber was deep with only mild
inflammation (1+ cellular reaction). On postoperative
day 5, the patient suffereds u d d e no c u l a rp a i ni nt h e
operated eye and repeatedly vomited. The visual acuity in
the left eye was 0.02, and IOP was 68 mmHg. The ante-
rior chamber was shallow, but severe corneal edema pre-
vented further detailed slit lamp examination. The
patient was treated with instillation of topical glaucoma
medication (0.5% timolol maleate) and systemic manni-
tol. IOP remained high in the 60 mmHg range despite
intensive anti-glaucoma therapy. A physician suspected
the presence of a thin membrane covering the pupil and
thus attempted Nd:YAG laser membranotomy, which
was unsuccessful due to corneal edema.
When the patient was transferred to Department of
Ophthalmology in Niigata University Hospital on post-
operative day 6, IOP was reduced to 16 mmHg in the
left eye, and the cornea became clear (Figure 1A). Slit
lamp examination revealed a thin membrane covering
the pupill, and the IOL was positioned at a distance
from the pupil (Figure 1B). Anterior segment optical
coherence tomography (AS-OCT) (SL-OCT; Heidelberg
Engineering, Heidelberg, Germany) (Figure 2) and ultra-
sound biomicroscopy (UBM) (Humphrey UBM model
840; Carl Zeiss Meditec, Dublin, CA) (Figure 3) further
confirmed a complete fibrin membrane across the pupil-
lary space. While the anterior chamber was shallow, the
posterior chamber was deep with a wide ciliary sulcus,
ruling out the possibility of malignant glaucoma (Figures
2 and 3). Although the IOL was not visualized with AS-
OCT, UBM, which has superior penetration, clearly
located the IOL deep in the posterior chamber. We
made a diagnosis of pupillary-block glaucoma due to a
complete fibrin membrane, and injected 25 μgo ft i s s u e
plasminogen activator (tPA) intracamerally. Usage of
tPA was a part of standard care for postoperative fibrin
reaction at our hospital. Within an hour, the fibrin
membrane was lysed (Figure 4). The anterior chamber
became deep, with IOP of 16 mmHg. On the day fol-
lowing tPA injection, IOP became elevated to 50 mmHg
presumably due to a response to topical steroids, since
IOP returned to the 10 mmHg range after tapering ster-
oid therapy. His ocular findings in the left eye as of
April 26, 2011 were as follows: visual acuity, 0.9; IOP,
12 mmHg.
Figure 1 Slit lamp examination on the day of transfer to our hospital (postoperative day 6).( A) Corneal edema resolved after systemic
glaucoma therapy. (B) The anterior chamber was shallow, resulting in peripheral iridocorneal contact over the entire circumference. A thin fibrin
membrane covered the pupil (arrow) while the IOL was located at a distance from the pupil (arrowhead).
Figure 2 Anterior segment OCT on the day of admission to our
hospital (postoperative day 6). The anterior chamber was very
shallow (0.46 mm). Anterior segment OCT clearly revealed a fibrin
membrane across the pupil (arrow) and iridocorneal contact. The
IOL was not observed by anterior segment OCT. Note the deep
posterior chamber.
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The differential diagnosis for a shallow anterior chamber
associated with elevated IOP after cataract surgery
includes pupillary block (fibrin membrane [1], Soem-
mering’s ring [2], and posterior synechia [3]), capsular
block syndrome [4], and malignant glaucoma [5].
Although fibrin membrane pupillary-block glaucoma is
more common after pars plana vitrectomy [6,7], there
are a few reports of fibrin membrane pupillary-block
glaucoma after cataract surgery [1,8].
Detection of a thin fibrin membrane by conventional
slit lamp examination is very difficult in the presence of
severe corneal edema associated with elevated IOP. In
contrast, UBM can visualize the anterior segment even
u n d e rp o o ri n t r a o c u l a rv i s i b i lity due to its echographic
nature. If UBM had been available in the acute phase of
IOP elevation in the present case, an immediate diagno-
sis would have been possible, leading to earlier treat-
ment. However, in the present case, the fibrin
membrane was observed only after the cornea became
clear following intensive glaucoma treatment including
systemic mannitol, which resulted in acute renal dys-
function in addition to the patient’s diabetic nephropa-
thy. As demonstrated in this case report, AS-OCT is a
useful diagnostic tool, but can only provide limited
information when the cornea is hazy. Moreover, since
AS-OCT has less penetration depth than UBM, it is dif-
ficult to examine the ciliary body, which is essential in
the evaluation of the possibility of malignant glaucoma.
In the present case, AS-OCT failed to visualize the IOL
located deep in the posterior chamber for the same rea-
son. We thus believe UBM has the strongest diagnostic
utility for acute angle closure as previously reported [9].
So far hypertension and diabetes mellitus have been
proposed as risk factors of fibrin formation after cataract
surgery [8,10]. In a large cohort study [8], accumulation
of fibrin after extracapsular cataract extraction was seen
more often in patients with diabetic retinopathy, but
only one patient with diabetes mellitus developed fibrin
pupillary block. Kohr et al. reported fibrin pupillary-
block glaucoma after phacoemulsification cataract sur-
gery in four patients, three of whom had diabetes melli-
tus [1]. Previous reports suggested that preposition to
breakdown of the blood-aqueous barrier in diabetics is
associated with fibrin formation after cataract surgery
[10,11]. Diabetes mellitus was also present in the present
patient.
The treatment of fibrin pupillary-block glaucoma has
not been established. In cases following pars plana
vitrectomy, it is often treated by laser peripheral
Figure 3 UBM on the day of admission to our hospital (postoperative day 6). (A) The fibrin membrane across the pupil was revealed by
UBM (arrow). The posterior chamber was extremely deep. (B) UBM localized the posterior chamber IOL (arrowhead) at a distance from the pupil.
The ciliary sulcus was very wide, ruling out the possibility of malignant glaucoma.
Figure 4 Slit lamp examination one hour after intracameral
tPA injection. The fibrin membrane had lysed, and the anterior
chamber deepened.
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series of fibrin pupillary-block glaucoma after phacoe-
mulsification cataract surgery, all patients were success-
fully treated by Nd:YAG laser peripheral iridotomy [1].
Two cases underwent Nd:YAG fibrin membranotomy,
but the fibrin membrane resealed in one patient [1]. Nd:
YAG laser iridotomy is a viable treatment option for
fibrin pupillary block, but it is technically difficult and
has the potential risk of damaging the corneal endothe-
lium when there is severe corneal edema or iridocorneal
contact. In a randomized prospective study of patients
with fibrin accumulation in the anterior chamber after
cataract surgery, a single anterior chamber injection of
tPA (10 μg) reduced the incidence and quantity of fibrin
without any adverse effects [12]. The advantage of ante-
rior chamber tPA injection is that the procedure can be
performed safely even in an eye with poor intraocular
visibility as long as careful sonographic examination was
performed using UBM.
Conclusions
Physicians have to include fibrin membrane pupillary
block in the differential diagnosis for shallow anterior
chamber after cataract surgery. UBM provides important
diagnostic information even in cases with severe corneal
edema. In this case, intracameral tPA injection was used
to successfully treat fibrin membrane pupillary block.
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